Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04364269
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia

Who this might be right for
Beta-ThalassemiaNon-transfusion-dependent Thalassemia
Vifor (International) Inc. 35
Early research (Phase 1)Study completedNCT05745727
What this trial is testing

Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels

Who this might be right for
Gout
Protalix 64
Early research (Phase 1)Study completedNCT01110590
What this trial is testing

Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552

Who this might be right for
Erectile Dysfunction
Bayer 37
Early research (Phase 1)Study completedNCT06206824
What this trial is testing

Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease

Who this might be right for
Healthy VolunteersDown SyndromeAlzheimer's Disease
Perha Pharmaceuticals 152
Early research (Phase 1)Not Yet RecruitingNCT07688980
What this trial is testing

Study to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or Intravenously (IV)

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 92
Early research (Phase 1)Study completedNCT05095168
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Ascending Dose (SAD) of CAN106 Administered Intravenously (IV) in Healthy Subjects

Who this might be right for
PNH
CARE Pharma Shanghai Ltd. 31
Early research (Phase 1)Study completedNCT03335956
What this trial is testing

CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)

Who this might be right for
Healthy
Corcept Therapeutics 48
Early research (Phase 1)Ended earlyNCT02012231
What this trial is testing

Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.

Who this might be right for
MelanomaThyroid CancerColorectal Cancer+4 more
Fore Biotherapeutics 5
Testing effectiveness (Phase 2)Looking for participantsNCT06314373
What this trial is testing

HSK39775 in Participants With Solid Tumors

Who this might be right for
Advanced Solid Tumors
Xizang Haisco Pharmaceutical Co., Ltd 243
Early research (Phase 1)Study completedNCT03980756
What this trial is testing

Compare PK, PD and Safety of the AD-206 and Esomeprazole

Who this might be right for
Gastritis
Addpharma Inc. 88
Early research (Phase 1)Study completedNCT00480467
What this trial is testing

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 32
Early research (Phase 1)Looking for participantsNCT07373457
What this trial is testing

A Phase I Study of HW201877 in Healthy Subjects

Who this might be right for
Healthy ParticipantsIBD (Inflammatory Bowel Disease)
Wuhan Humanwell Innovative Drug Research and Development Center Limited Company 104
Large-scale testing (Phase 3)Study completedNCT04902781
What this trial is testing

Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia

Who this might be right for
Classic Galactosemia
Applied Therapeutics, Inc. 47
Early research (Phase 1)Study completedNCT04867057
What this trial is testing

Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation

Who this might be right for
HealthyOsteoarthritis
ZYUS Life Sciences Inc. 41
Early research (Phase 1)Study completedNCT01800305
What this trial is testing

PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual

Who this might be right for
Healthy
Xiamen Amoytop Biotech Co., Ltd. 150
Early research (Phase 1)Study completedNCT01262794
What this trial is testing

Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects

Who this might be right for
Healthy Volunteers
UCB Pharma 20
Early research (Phase 1)Study completedNCT07331545
What this trial is testing

Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis(MASH)
Qilu Pharmaceutical Co., Ltd. 71
Testing effectiveness (Phase 2)UnknownNCT05048160
What this trial is testing

A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm

Who this might be right for
Advanced Malignant Neoplasm
Mabwell (Shanghai) Bioscience Co., Ltd. 272
Early research (Phase 1)Study completedNCT02914262
What this trial is testing

Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers

Who this might be right for
IBD
Aerpio Therapeutics 40
Early research (Phase 1)Enrolling By InvitationNCT06115642
What this trial is testing

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Malignant Solid Tumors
Shanghai Henlius Biotech 367
Next Page